SCHEMBL17875810

SCHEMBL17875810

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)-c3cc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)ccc3CSC4)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
MYC P01106 1/20 0.40
TYRO3 Q06418 1/20 0.39
NTRK2 Q16620 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
MAPT P10636 3/20 0.38
MCL1 Q07820 2/20 0.38
KDM4E B2RXH2 2/20 0.38
CTRC Q99895 1/20 0.37
ADORA1 P30542 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36
RAB9A P51151 2/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875809 0.97 MAPT (0.40) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL17875757 0.94 CYP19A1 (0.38) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL17875751 0.94 CYP19A1 (0.38) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL17875787 0.91 MAPT (0.37) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL17875791 0.89 TYRO3 (0.46) MEN1KMT2ATYRO3NTRK2CLK4
SCHEMBL17875807 0.88 CYP19A1 (0.55) CYP19A1KDM4ERAB9AALDH1A1NPC1
SCHEMBL19368666 0.84 CYP19A1 (0.46) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL19368548 0.84 CYP19A1 (0.46) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL17875754 0.84 CYP19A1 (0.50) CYP19A1KDM4ERAB9AALDH1A1TDP2
SCHEMBL17875770 0.84 CYP19A1 (0.50) CYP19A1KDM4ERAB9AALDH1A1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP19A1 167/4885MEN1 448/4885KMT2A 1757/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP19A1 167/4885MEN1 448/4885KMT2A 1757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.